Related Experiment Video
Updated: Aug 7, 2026

05:45
Cultivating Ex Vivo Patient-Derived Glioma Organoids Using a Tissue Chopper
Published on: January 19, 2024
Low-grade gliomas in adults
Jeanine T Grier1, Tracy Batchelor
1Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
The Oncologist
|June 24, 2006
Summary
Low-grade gliomas pose challenges due to long survival and treatment risks. Identifying aggressive subtypes aids in tailored management for better patient outcomes.
Area of Science:
- Neuro-oncology
- Pediatric oncology
- Neurosurgery
Background:
- Low-grade gliomas (LGGs) are diverse brain tumors common in young patients.
- LGGs present management challenges due to long patient survival and potential treatment complications.
- A subset of LGGs exhibits aggressive behavior, necessitating early, intensive intervention.
Purpose of the Study:
- To explore clinical and molecular factors for improved prognosis assessment in LGGs.
- To guide risk-adjusted management strategies for low-grade gliomas.
- To highlight the need for enhanced long-term cognitive and functional assessments in LGG patients.
Main Methods:
- Review of clinical observations and molecular parameters in LGG cases.
- Analysis of treatment strategies including resection, radiation, and chemotherapy.
- Assessment of long-term patient outcomes and quality of life.
Main Results:
- Identification of specific clinical and molecular markers associated with aggressive LGG behavior.
- Correlation between risk stratification and the need for intensified treatment approaches.
- Demonstration of significant gaps in current long-term cognitive and functional assessment methods.
Conclusions:
- Clinical and molecular profiling can refine prognosis and guide personalized management of low-grade gliomas.
- Risk-adjusted strategies are crucial for optimizing treatment and minimizing complications in LGGs.
- Development of improved long-term assessment tools is essential for this patient population.

